Want to see SRXH full AI Analyst Report?
SRXH Stock Chart & Stats
$0.24
--
Market closed
$0.24
--
Day’s Range― - ―
52-Week Range$0.08 - $0.78
Previous CloseN/A
VolumeN/A
Average Volume (3M)695.52K
Market Cap
$53.54M
Enterprise Value$8.86M
Total Cash (Recent Filing)$26.07M
Total Debt (Recent Filing)$22.62M
Price to Earnings (P/E)―
Beta0.22
Next Earnings
May 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-213365.32
Shares Outstanding590,254,760
10 Day Avg. Volume504,141
30 Day Avg. Volume695,518
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)16.44
Price to Sales (P/S)1.02
P/FCF Ratio-0.82
Enterprise Value/Market Cap0.17
Enterprise Value/Revenue-0.29
Enterprise Value/Gross Profit-1.08
Enterprise Value/Ebitda-0.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.32
Revenue Forecast (FY)$95.00M
Bulls Say, Bears Say
Bulls Say
Strategic Pivot And EMJ Crypto AcquisitionAcquiring EMJ Crypto and rebranding to an AI-driven capital allocation platform materially broadens the business model beyond specialty pharmacy. This structural pivot creates new operating optionality and recurring treasury-management capabilities that can generate non-operational returns and diversify revenue sources over the medium term.
Active Treasury Deployment Into AI/space And Listed EquitiesDeliberate redeployment of investable capital into high-growth themes and public equities indicates a managed-treasury approach that can produce structural returns independent of core pharmacy operations. If executed prudently, this diversifies cash generation sources and leverages portfolio returns to support the company’s strategic objectives.
Recent Improvement In Reported EquityA shift from negative to positive equity provides a more durable capitalization cushion, reducing immediate insolvency risk and improving the company’s ability to pursue strategic initiatives. This structural balance-sheet improvement, if sustained, lowers refinancing urgency and supports execution of the pivot over coming quarters.
Bears Say
Extremely Elevated LeverageVery high leverage materially constrains financial flexibility, increases borrowing costs, and raises default or covenant-risk under stress. Over a multi-month horizon, elevated debt burdens limit the company’s ability to fund operations or invest in the pivot without further dilutive financing or asset sales, amplifying execution risk.
Persistent Negative Operating Cash FlowSustained cash burn undermines long-term sustainability because operations do not self-fund growth or strategic initiatives. Continued negative operating and free cash flow forces reliance on external financing, increasing dilution and refinancing risk, and reduces runway to realize benefits from the new AI/treasury strategy.
Listing Compliance And Capital-structure ActionsA reverse split and trading suspension reflect persistent market-listing and liquidity problems, signaling governance or investor-confidence weaknesses. These structural issues impede access to public capital and complicate shareholder returns, raising medium-term risks around liquidity, secondary financing, and credibility with institutional partners.
SRx Health Solutions News
SRXH FAQ
What was SRx Health Solutions’s price range in the past 12 months?
SRx Health Solutions lowest stock price was $0.08 and its highest was $0.78 in the past 12 months.
What is SRx Health Solutions’s market cap?
SRx Health Solutions’s market cap is $53.54M.
When is SRx Health Solutions’s upcoming earnings report date?
SRx Health Solutions’s upcoming earnings report date is May 20, 2027 which is in 318 days.
How were SRx Health Solutions’s earnings last quarter?
SRx Health Solutions released its earnings results on May 14, 2026. The company reported -$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.021.
Is SRx Health Solutions overvalued?
According to Wall Street analysts SRx Health Solutions’s price is currently Overvalued.
Does SRx Health Solutions pay dividends?
SRx Health Solutions does not currently pay dividends.
What is SRx Health Solutions’s EPS estimate?
SRx Health Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SRx Health Solutions have?
SRx Health Solutions has 590,254,760 shares outstanding.
What happened to SRx Health Solutions’s price movement after its last earnings report?
SRx Health Solutions reported an EPS of -$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.42%.
Which hedge fund is a major shareholder of SRx Health Solutions?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SRx Health Solutions Stock Smart Score
Company Description
SRx Health Solutions
SRX Global Inc. develops artificial intelligence (AI)-powered solutions designed to improve decision-making, streamline operations, and strengthen risk management. The company is headquartered in Tampa, Florida.
Technical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
0.28% Insiders
0.02% Mutual Funds
0.04% Other Institutional Investors
99.67% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---